Egfr amplification specific gene expression in phyllodes tumours of the breast

Konstantin Agelopoulos, Christian Kersting, Eberhard Korsching, Hartmut Schmidt, Arno Kuijper, Christian August, Pia Wülfing, Joke Tio, Werner Boecker, Paul J. Van Diest, Burkhard Brandt, Horst Buerger

Research output: Contribution to journalArticle

Abstract

Background: Recently, we were able to show that amplifications of the epidermal growth factor receptor (egfr) gene and the overexpression of EGFR were associated with the initiation and progression of phyllodes tumours. Methods: In order to gain further insights into regulation mechanisms associated with egfr amplifications and EGFR expression in phyllodes tumours, we performed global gene expression analysis (Affymetrix A133.2) on a series of 10 phyllodes tumours, of these three with and seven without amplifications of an important regulatory repeat in intron 1 of egfr (CA-SSR I). The results were verified and extended by means of immunohistochemistry using the tissue microarray method on an extensively characterized series of 58 phyllodes tumours with antibodies against caveolin-1, eps15, EGF, TGF-α, pErk, pAkt and mdm2. Results: We were able to show that the presence of egfr CA-SSR I amplifications in phyllodes tumours was associated with 230 differentially expressed genes. Caveolin-1 and eps15, involved in EGFR turnover and signalling, were regulated differentially on the RNA and protein level proportionally to egfr gene dosage. Further immunohistochemical analysis revealed that the expression of caveolin-1 and eps15 were also significantly correlated with the expression of pAkt (p

Original languageEnglish (US)
Pages (from-to)443-451
Number of pages9
JournalCellular Oncology
Volume29
Issue number6
StatePublished - 2007
Externally publishedYes

Fingerprint

Phyllodes Tumor
Breast
Caveolin 1
Gene Expression
Epidermal Growth Factor Receptor
erbB-1 Genes
Neoplasm Antibodies
Gene Dosage
Epidermal Growth Factor
Introns
Immunohistochemistry
RNA
Genes
Proteins

Keywords

  • Caveolin-1
  • egfr
  • Eps15
  • Phyllodes tumours

ASJC Scopus subject areas

  • Cell Biology
  • Pathology and Forensic Medicine
  • Oncology

Cite this

Agelopoulos, K., Kersting, C., Korsching, E., Schmidt, H., Kuijper, A., August, C., ... Buerger, H. (2007). Egfr amplification specific gene expression in phyllodes tumours of the breast. Cellular Oncology, 29(6), 443-451.

Egfr amplification specific gene expression in phyllodes tumours of the breast. / Agelopoulos, Konstantin; Kersting, Christian; Korsching, Eberhard; Schmidt, Hartmut; Kuijper, Arno; August, Christian; Wülfing, Pia; Tio, Joke; Boecker, Werner; Van Diest, Paul J.; Brandt, Burkhard; Buerger, Horst.

In: Cellular Oncology, Vol. 29, No. 6, 2007, p. 443-451.

Research output: Contribution to journalArticle

Agelopoulos, K, Kersting, C, Korsching, E, Schmidt, H, Kuijper, A, August, C, Wülfing, P, Tio, J, Boecker, W, Van Diest, PJ, Brandt, B & Buerger, H 2007, 'Egfr amplification specific gene expression in phyllodes tumours of the breast', Cellular Oncology, vol. 29, no. 6, pp. 443-451.
Agelopoulos K, Kersting C, Korsching E, Schmidt H, Kuijper A, August C et al. Egfr amplification specific gene expression in phyllodes tumours of the breast. Cellular Oncology. 2007;29(6):443-451.
Agelopoulos, Konstantin ; Kersting, Christian ; Korsching, Eberhard ; Schmidt, Hartmut ; Kuijper, Arno ; August, Christian ; Wülfing, Pia ; Tio, Joke ; Boecker, Werner ; Van Diest, Paul J. ; Brandt, Burkhard ; Buerger, Horst. / Egfr amplification specific gene expression in phyllodes tumours of the breast. In: Cellular Oncology. 2007 ; Vol. 29, No. 6. pp. 443-451.
@article{025c92063c454f9cb5e3fc30866560fd,
title = "Egfr amplification specific gene expression in phyllodes tumours of the breast",
abstract = "Background: Recently, we were able to show that amplifications of the epidermal growth factor receptor (egfr) gene and the overexpression of EGFR were associated with the initiation and progression of phyllodes tumours. Methods: In order to gain further insights into regulation mechanisms associated with egfr amplifications and EGFR expression in phyllodes tumours, we performed global gene expression analysis (Affymetrix A133.2) on a series of 10 phyllodes tumours, of these three with and seven without amplifications of an important regulatory repeat in intron 1 of egfr (CA-SSR I). The results were verified and extended by means of immunohistochemistry using the tissue microarray method on an extensively characterized series of 58 phyllodes tumours with antibodies against caveolin-1, eps15, EGF, TGF-α, pErk, pAkt and mdm2. Results: We were able to show that the presence of egfr CA-SSR I amplifications in phyllodes tumours was associated with 230 differentially expressed genes. Caveolin-1 and eps15, involved in EGFR turnover and signalling, were regulated differentially on the RNA and protein level proportionally to egfr gene dosage. Further immunohistochemical analysis revealed that the expression of caveolin-1 and eps15 were also significantly correlated with the expression of pAkt (p",
keywords = "Caveolin-1, egfr, Eps15, Phyllodes tumours",
author = "Konstantin Agelopoulos and Christian Kersting and Eberhard Korsching and Hartmut Schmidt and Arno Kuijper and Christian August and Pia W{\"u}lfing and Joke Tio and Werner Boecker and {Van Diest}, {Paul J.} and Burkhard Brandt and Horst Buerger",
year = "2007",
language = "English (US)",
volume = "29",
pages = "443--451",
journal = "Cellular Oncology",
issn = "1570-5870",
publisher = "IOS Press",
number = "6",

}

TY - JOUR

T1 - Egfr amplification specific gene expression in phyllodes tumours of the breast

AU - Agelopoulos, Konstantin

AU - Kersting, Christian

AU - Korsching, Eberhard

AU - Schmidt, Hartmut

AU - Kuijper, Arno

AU - August, Christian

AU - Wülfing, Pia

AU - Tio, Joke

AU - Boecker, Werner

AU - Van Diest, Paul J.

AU - Brandt, Burkhard

AU - Buerger, Horst

PY - 2007

Y1 - 2007

N2 - Background: Recently, we were able to show that amplifications of the epidermal growth factor receptor (egfr) gene and the overexpression of EGFR were associated with the initiation and progression of phyllodes tumours. Methods: In order to gain further insights into regulation mechanisms associated with egfr amplifications and EGFR expression in phyllodes tumours, we performed global gene expression analysis (Affymetrix A133.2) on a series of 10 phyllodes tumours, of these three with and seven without amplifications of an important regulatory repeat in intron 1 of egfr (CA-SSR I). The results were verified and extended by means of immunohistochemistry using the tissue microarray method on an extensively characterized series of 58 phyllodes tumours with antibodies against caveolin-1, eps15, EGF, TGF-α, pErk, pAkt and mdm2. Results: We were able to show that the presence of egfr CA-SSR I amplifications in phyllodes tumours was associated with 230 differentially expressed genes. Caveolin-1 and eps15, involved in EGFR turnover and signalling, were regulated differentially on the RNA and protein level proportionally to egfr gene dosage. Further immunohistochemical analysis revealed that the expression of caveolin-1 and eps15 were also significantly correlated with the expression of pAkt (p

AB - Background: Recently, we were able to show that amplifications of the epidermal growth factor receptor (egfr) gene and the overexpression of EGFR were associated with the initiation and progression of phyllodes tumours. Methods: In order to gain further insights into regulation mechanisms associated with egfr amplifications and EGFR expression in phyllodes tumours, we performed global gene expression analysis (Affymetrix A133.2) on a series of 10 phyllodes tumours, of these three with and seven without amplifications of an important regulatory repeat in intron 1 of egfr (CA-SSR I). The results were verified and extended by means of immunohistochemistry using the tissue microarray method on an extensively characterized series of 58 phyllodes tumours with antibodies against caveolin-1, eps15, EGF, TGF-α, pErk, pAkt and mdm2. Results: We were able to show that the presence of egfr CA-SSR I amplifications in phyllodes tumours was associated with 230 differentially expressed genes. Caveolin-1 and eps15, involved in EGFR turnover and signalling, were regulated differentially on the RNA and protein level proportionally to egfr gene dosage. Further immunohistochemical analysis revealed that the expression of caveolin-1 and eps15 were also significantly correlated with the expression of pAkt (p

KW - Caveolin-1

KW - egfr

KW - Eps15

KW - Phyllodes tumours

UR - http://www.scopus.com/inward/record.url?scp=36248936581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36248936581&partnerID=8YFLogxK

M3 - Article

C2 - 18032821

AN - SCOPUS:36248936581

VL - 29

SP - 443

EP - 451

JO - Cellular Oncology

JF - Cellular Oncology

SN - 1570-5870

IS - 6

ER -